BioWorld

March 7, 2003

View Archived Issues

Mice Sans Cytochrome Gene Have Ocular Drainage Irregularities That Mimic Human Congenital Glaucoma

Interleukin Cedes Majority Interest To Alticor Through Collaboration

Northfield Gets FDA Approval For Phase III Trial Of PolyHeme

PanCel Gets Telomerase License From Geron For Diabetes Program

Other News To Note

Correction

U.S. Patent Disclosures

FDA Head Says Administration Has Hatch-Waxman Under Control

WASHINGTON - FDA Commissioner Mark McClellan told a House subcommittee Thursday that legislation to close loopholes in the Hatch-Waxman Act is not necessary. (BioWorld Today) Read More

ImClone Receives $60M Payment As Part Of Revamped BMS Deal

Today's news in brief

BioWorld

BioWorld briefs for April 17, 2026.

Man holding raised arm with illustrated overlay of nerves

Biohaven reports details on discovery of BHV-2100

BioWorld Science

Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...

Elderly woman holding illustration of brain with missing puzzle piece

Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

BioWorld

The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...

New GABA(B) receptor PAMs revealed in Addex Pharma patents

BioWorld Science

Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...

Novel caspase-2 inhibitor shows in vivo neuroprotective effects

BioWorld Science

Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...